Ibuprofen/Paracetamol Alkaloid-Int (Ibuprofen, Paracetamol)

The product combines two mechanisms: ibuprofen blocks cyclo‑oxygenase enzymes, lowering prostaglandin production to reduce pain, fever, and inflammation; paracetamol acts centrally on a brain‑specific cyclo‑oxygenase variant and serotonergic pathways, providing additional analgesic and antipyretic effects. Together they give additive symptom control.

The appropriate dose is set by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and any relevant medical history. Dosage recommendations are not standardized in this description and should follow the prescriber’s instructions.

Safety data for the combination in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any risk, and only under medical supervision. Women who are pregnant, planning pregnancy, or breastfeeding should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with ibuprofen alone, the ibuprofen/paracetamol combination can achieve comparable pain relief and fever reduction at lower individual doses of each component, potentially reducing the risk of gastrointestinal irritation from ibuprofen while adding the central analgesic effect of paracetamol. Clinical choice depends on the patient’s response and safety profile.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep it out of reach of children and do not use after the expiry date indicated on the label.

The medication is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help minimise stomach discomfort. The exact timing and frequency should follow the prescribing clinician’s directions.

Serious risks include gastrointestinal bleeding (e.g., black stools or vomiting blood), severe skin reactions such as Stevens‑Johnson syndrome, and liver injury manifested by jaundice, dark urine, or elevated liver enzymes. Any of these signs require immediate medical attention.

Individuals with known hypersensitivity to ibuprofen, paracetamol, or any excipients should avoid the product. It is also contraindicated in patients with active peptic ulcer disease, severe liver or kidney impairment, and in children for whom the formulation is not approved. Consultation with a healthcare professional is essential before use.